Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory diseaseFrançois Danion, Xavier Mariette, Yves‐Marie Pers et al.|Lupus|2016Cited by 24
Biofármacos y terapias dirigidas mediante pequeñas moléculas inmunosupresorasRenaud Felten, Jean Sibilia, Florence Scher et al.|EMC - Tratado de Medicina|2020Cited by 1
SAT0059 Criteria for Choice by Clincians of The Therapeutic Strategy in Patients with Insufficient Response To A First Anti-TNF: Data from The Randomized “Roc” CriteriaEmmanuel Chatelus, J.E. Gottenberg, Christelle Sordet et al.|Annals of the Rheumatic Diseases|2016Cited by 0
Stratégies d’arrêt ou de réduction des biomédicaments dans la polyarthrite rhumatoïde en rémissionAuriane Mallick, Jean Sibilia, Bruno Fautrel et al.|La Revue de Médecine Interne|2017Cited by 0
THU0364 SYSTEMIC SCLEROSIS OVERLAP AND NON-OVERLAP SYNDROMES SHARE SIMILAR CLINICAL CHARACTERISTICS BUT DRAMATICALLY DIFFERENT TREATMENT.Marc Scherlinger, Marie‐Elise Truchetet, Jean-Christophe Lutz et al.|Annals of the Rheumatic Diseases|2020Cited by 0